SpeeDx releases Compact Respiratory Multiplex in advance of UK winter

Upfront diagnosis. Combat seasonal testing surges with ease


PlexPCR® Flu/RSV/SARS-CoV-2 detects Influenza, Respiratory Syncytial Virus and SARS-CoV-2 virus in a single-well multiplex qPCR test. Prompt identification of these viral infections can be important for patient management. In addition, prioritising diagnosis of these common seasonal infections with a uniform testing approach can improve laboratory efficiency and productivity during seasonal testing surges.

Seasonal respiratory surges are known to push the limits of testing capacity for many laboratories.” explained Warwick Need, Director of Sales, SpeeDx. “Adopting PlexPCR® Flu/RSV/SARS-CoV-2 can ease the pressure, by funnelling all respiratory swabs into a single test and, only where needed, reflexing to an extended respiratory virus panel, like PlexPCR® RespiVirus.

Read full Press Release here